| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | 0 | 0 | 0 | 0 | 8.745 | 0 | 0 | 0 | 0 | 0 |
| Total Income - EUR | 0 | 0 | 0 | 0 | 8.745 | 0 | 0 | 0 | 0 | 0 |
| Total Expenses - EUR | 0 | 0 | 467 | 0 | 207 | 185 | 215 | 0 | 795 | 76 |
| Gross Profit/Loss - EUR | 0 | 0 | -467 | 0 | 8.538 | -185 | -215 | 0 | -795 | -76 |
| Net Profit/Loss - EUR | 0 | 0 | -467 | 0 | 8.276 | -185 | -215 | 0 | -795 | -76 |
| Employees | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Check the financial reports for the company - Novotech Medical Srl
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Current Assets | 499 | 494 | 19 | 19 | 13 | 10 | 42 | 0 | -3 | -8 |
| Inventories | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Receivables | 480 | 475 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Cash | 20 | 19 | 19 | 19 | 13 | 10 | 42 | 0 | -3 | -8 |
| Shareholders Funds | -14.394 | -14.247 | -14.473 | -14.207 | -5.656 | -5.734 | -5.822 | 0 | -6.803 | -6.841 |
| Social Capital | 135 | 134 | 131 | 129 | 126 | 124 | 121 | 0 | 121 | 121 |
| Debts | 14.893 | 14.741 | 14.492 | 14.226 | 5.670 | 5.744 | 5.864 | 0 | 6.801 | 6.833 |
| Income in Advance | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "3313 - 3313" | |||||||||
| CAEN Financial Year |
3313
|
|||||||||
Comments - Novotech Medical Srl